Illinois Municipal Retirement Fund lessened its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) by 4.9% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 45,078 shares of the company’s stock after selling 2,331 shares during the period. Illinois Municipal Retirement Fund’s holdings in Pediatrix Medical Group were worth $653,000 at the end of the most recent reporting period.
A number of other large investors have also added to or reduced their stakes in MD. American Century Companies Inc. raised its holdings in Pediatrix Medical Group by 628.2% in the fourth quarter. American Century Companies Inc. now owns 1,739,323 shares of the company’s stock worth $22,820,000 after buying an additional 1,500,485 shares during the last quarter. Oberweis Asset Management Inc. bought a new stake in shares of Pediatrix Medical Group during the fourth quarter valued at approximately $6,122,000. Renaissance Technologies LLC raised its holdings in Pediatrix Medical Group by 117.4% in the 4th quarter. Renaissance Technologies LLC now owns 838,800 shares of the company’s stock worth $11,005,000 after acquiring an additional 453,000 shares during the last quarter. Boston Partners lifted its position in Pediatrix Medical Group by 25.2% in the 4th quarter. Boston Partners now owns 1,956,353 shares of the company’s stock valued at $25,922,000 after acquiring an additional 393,600 shares in the last quarter. Finally, Nomura Holdings Inc. bought a new position in Pediatrix Medical Group in the 4th quarter valued at approximately $3,882,000. Hedge funds and other institutional investors own 97.71% of the company’s stock.
Wall Street Analyst Weigh In
A number of analysts have commented on MD shares. Macquarie lifted their target price on Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an “outperform” rating in a report on Thursday, May 8th. Truist Financial reduced their price objective on Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating for the company in a report on Friday, April 11th. Finally, UBS Group lowered their target price on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a “neutral” rating on the stock in a research note on Monday, May 12th. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $16.67.
Pediatrix Medical Group Stock Down 4.0%
Pediatrix Medical Group stock opened at $13.76 on Thursday. Pediatrix Medical Group, Inc. has a one year low of $6.62 and a one year high of $17.67. The stock has a fifty day moving average of $13.83 and a 200 day moving average of $13.91. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.81 and a current ratio of 1.81. The stock has a market cap of $1.18 billion, a PE ratio of -13.62, a price-to-earnings-growth ratio of 0.97 and a beta of 1.25.
Pediatrix Medical Group (NYSE:MD – Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.25 by $0.08. Pediatrix Medical Group had a positive return on equity of 17.43% and a negative net margin of 4.17%. The business had revenue of $458.36 million during the quarter, compared to the consensus estimate of $451.44 million. During the same period in the previous year, the company posted $0.20 EPS. The business’s quarterly revenue was down 7.4% compared to the same quarter last year. As a group, sell-side analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.
About Pediatrix Medical Group
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
Recommended Stories
- Five stocks we like better than Pediatrix Medical Group
- 3 REITs to Buy and Hold for the Long Term
- Jefferies Raises Broadcom Price Target to $315: 19% Upside Ahead
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Whiplash for Investors: AeroVironment’s Confusing Stock Signals
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- The Ultimate Trump Bump: These Gov’t Backed Stocks Are Exploding
Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD – Free Report).
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.